Zydus' Nesher Pharmaceuticals receives final approval for Oseltamivir Phosphate capsules

Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received final approval from the USFDA to market Oseltamivir Phosphate Capsules, USP in strengths of 30mg, 45mg, and 75mg.

February 27, 2017 / 12:36 IST

live

bselive
nselive

Volume

Todays L/H

Cadila Healthcare Ltd has informed BSE regarding a Press Release dated February 27, 2017 titled "Zydus' Nesher Pharmaceuticals receives final approval from the USFDA for Oseltamivir Phosphate Capsules".Source : BSE

Read all announcements in Cadila Health

first published: Feb 27, 2017 12:36 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347